Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bevida is a parenteral vitamin B-complex formulation developed and manufactured by Euro-Med Laboratories in the Philippines. It typically consists of a combination of Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), and Cyanocobalamin (Vitamin B12). The drug is indicated for the treatment and prevention of vitamin B deficiencies and is frequently used in the management of neurological conditions such as neuritis, polyneuritis, and neuralgia. As a solution for injection, Bevida provides rapid replenishment of essential cofactors required for carbohydrate metabolism, amino acid synthesis, and the maintenance of the myelin sheath in nerve cells. It is commercially available in the Philippines as an approved pharmaceutical product for intramuscular or intravenous administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bevida.